Interações medicamentosas
Nirsevimab + Palivizumab
Gravidade: Moderada
Nirsevimab and Palivizumab: moderate interaction.
Última atualização
Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.
O conteúdo clínico desta página está disponível apenas em inglês.
Resumo
Both are monoclonal antibodies that provide passive RSV protection and are used for the same indication. Giving both offers no added benefit and exposes the infant to unnecessary dosing.
O que esta interação significa em palavras simples
Nirsevimab and Palivizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Nirsevimab belongs to Miscellaneous; Palivizumab belongs to Miscellaneous.
Por que acontece
Therapeutic duplication of RSV F-protein-targeting antibodies; no pharmacokinetic interaction is established.
O que fazer
Do not give palivizumab to infants who have already received nirsevimab in the same RSV season. For infants who had palivizumab first, follow the labeled guidance on switching.
O que perguntar ao farmacêutico
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Para assinantes do Pro+
Desbloqueie a página completa
Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Nirsevimab e Palivizumab, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Experimente o Pro+ grátis por 7 dias na web. Sem cartão.
Perguntas frequentes
Can I take Nirsevimab with Palivizumab?
MediHelp rates the interaction as moderate. Nirsevimab and Palivizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both are monoclonal antibodies that provide passive RSV protection and are used for the same indication. Giving both offers no added benefit and exposes the infant to unnecessary dosing.
How serious is the interaction between Nirsevimab and Palivizumab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not give palivizumab to infants who have already received nirsevimab in the same RSV season. For infants who had palivizumab first, follow the labeled guidance on switching.
Monografias completas, posologia e verificador de interações no app MediHelp
Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.
